Article Type
Article
Changed
Thu, 12/15/2022 - 15:10
Display Headline
Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II
Author(s)
Moberg P
Charles JF
Respicio G
Venna SS
Rooney T

Article PDF
086030133.pdf
Author and Disclosure Information

Moberg P, Charles JF, Respicio G, Venna SS, Rooney T

Issue
Cutis - 86(3)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
133-135
Sections
Clinical Topics & News
Author(s)
Moberg P
Charles JF
Respicio G
Venna SS
Rooney T
Author(s)
Moberg P
Charles JF
Respicio G
Venna SS
Rooney T
Author and Disclosure Information

Moberg P, Charles JF, Respicio G, Venna SS, Rooney T

Author and Disclosure Information

Moberg P, Charles JF, Respicio G, Venna SS, Rooney T

Article PDF
086030133.pdf
Article PDF
086030133.pdf

Issue
Cutis - 86(3)
Issue
Cutis - 86(3)
Page Number
133-135
Page Number
133-135
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II
Display Headline
Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II
Sections
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media